Patents Assigned to Sun Pharmaceutical Industries Limited
  • PERFUSION DOSAGE FORM
    Publication number: 20190046398
    Abstract: The present invention relates to a method for enabling hospitals or clinics to administer a dose of a drug to patients in need thereof while avoiding steps of manipulation, dilution, reconstitution, dispensing, sterilization, transfer, handling or compounding before intravenous administration. The present invention further relates to a perfusion system comprising different sets of perfusion containers, each container comprising a ready-to-infuse, stable, sterile, aqueous perfusion solution of a drug, wherein the set of perfusion containers alone or in combination provides for direct intravenous administration of a desired dose of the drug to a patient in need thereof, such that the delivered dose is equal to or within ±5% of the calculated dose.
    Type: Application
    Filed: October 12, 2018
    Publication date: February 14, 2019
    Applicant: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Samarth KUMAR, Prashant KANE, Subhas Balaram BHOWMICK, Kirti GANORKAR, Nishit PATEL, Ashish Anilrao DUBEWAR, Umeshkumar Mukeshbhai PATEL
  • Process for the preparation of ibrutinib
    Patent number: 10196397
    Abstract: The present invention provides processes for the preparation of ibrutinib, intermediate compounds of Formula VI and Formula VIII, and salts thereof. The processes of the present invention are commercially viable, cost-effective, environmentally friendly, and make use of inexpensive, non-hazardous, safe chemicals that are easy to handle.
    Type: Grant
    Filed: November 18, 2015
    Date of Patent: February 5, 2019
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Kapil Sharma, Bhavin Prabhudas Thanki, Mahavir Singh Khanna, Mohan Prasad
  • PHARMACEUTICAL COMPOSITIONS OF DIMETHYL FUMARATE
    Publication number: 20180369183
    Abstract: The present invention relates to pharmaceutical compositions comprising dimethyl fumarate and a pharmaceutically acceptable agent which inhibits the enzyme catalyzed degradation of dimethyl fumarate.
    Type: Application
    Filed: August 29, 2018
    Publication date: December 27, 2018
    Applicant: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Rajamannar THENNATI, Shirish KULKARNI, Amol KULKARNI, Vimal KANERIA, Mukesh SHARMA
  • Gastroretentive dosage system and process of preparation thereof
    Patent number: 10137094
    Abstract: The present invention relates to novel gastroretentive dosage systems, in particular, a floating capsule which releases the drug without any lag time and which remains buoyant for a sufficient period of time in the stomach. Further, the invention relates to the process of preparation thereof.
    Type: Grant
    Filed: October 11, 2012
    Date of Patent: November 27, 2018
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Varinder Kumar, Shavej Ahmad, Romi Barat Singh
  • Salts of nilotinib and polymorphs thereof
    Patent number: 10138221
    Abstract: The present invention provides novel salts of nilotinib and polymorphs thereof. The acid addition salts of nilotinib with benzenesulfonic acid, butanedisulfonic acid, 1-5-naphthalenedisulfonic acid, naphthalene-1-sulfonic acid and 1-hydroxynaph-thoic acid; hydrates and anhydrates thereof.
    Type: Grant
    Filed: August 10, 2015
    Date of Patent: November 27, 2018
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Rajamannar Thennati, Srinivasu Kilaru, Macwan Valance Surendrakumar, Dwivedi Shriprakash Dhar
  • Topical pharmaceutical composition of acitretin
    Patent number: 10123987
    Abstract: The present invention relates to a topical pharmaceutical composition comprising acitretin and a process for its preparation. It also relates to a method of treating skin disorders by administering said topical pharmaceutical composition.
    Type: Grant
    Filed: October 30, 2014
    Date of Patent: November 13, 2018
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Rathinasabapathy Venkateshwaran, Vikas Jain, Vaibhav Dubey, Sumit Madan, Vinod Kumar Arora, Rajesh Rao
  • Topical retinoid solutions
    Patent number: 10123970
    Abstract: The present invention relates to a topical solution comprising a retinoid or its pharmaceutically acceptable salts thereof and a process of preparing it.
    Type: Grant
    Filed: May 20, 2010
    Date of Patent: November 13, 2018
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Sanjay Kumar Motwani, Shashikanth P. Isloor, Vinod Arora
  • Perfusion dosage form
    Patent number: 10098813
    Abstract: The present invention relates to a method for enabling hospitals or clinics to administer a dose of a drug to patients in need thereof while avoiding steps of manipulation, dilution, reconstitution, dispensing, sterilization, transfer, handling or compounding before intravenous administration. The present invention further relates to a perfusion system comprising different sets of perfusion containers, each container comprising a ready-to-infuse, stable, sterile, aqueous perfusion solution of a drug, wherein the set of perfusion containers alone or in combination provides for direct intravenous administration of a desired dose of the drug to a patient in need thereof, such that the delivered dose is equal to or within ±5% of the calculated dose.
    Type: Grant
    Filed: September 2, 2015
    Date of Patent: October 16, 2018
    Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Samarth Kumar, Prashant Kane, Balaram Subhas Bhowmick, Kirti Ganorkar, Nishit Patel, Anilrao Ashish Dubewar, Mukeshbhai Umeshkumar Patel
  • Pharmaceutical compositions of dimethyl fumarate
    Patent number: 10085961
    Abstract: The present invention relates to pharmaceutical compositions comprising dimethyl fumarate and a pharmaceutically acceptable agent which inhibits the enzyme catalyzed degradation of dimethyl fumarate.
    Type: Grant
    Filed: June 1, 2016
    Date of Patent: October 2, 2018
    Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Rajamannar Thennati, Shirish Kulkarni, Amol Kulkarni, Vimal Kaneria, Mukesh Sharma
  • STABLE CRYSTALLINE FORM OF REGADENOSON
    Publication number: 20180208622
    Abstract: The present invention provides crystalline Form S of regadenoson which is substantially free of residual organic solvent and having an X-ray powder diffraction pattern comprising characteristic peak at 10.3, 10.8, 19.0, 21.6 and 25.5±0.2 degrees 2?.
    Type: Application
    Filed: September 10, 2016
    Publication date: July 26, 2018
    Applicant: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Rajamannar THENNATI, Shriprakash Dhar DWIVEDI, Arunkumar Gulabsingh YADAV, Nischalkumar Vinodbhai PATEL, Sunil Rajaram KARANKE
  • Topical solution of isotretinoin
    Patent number: 10022348
    Abstract: The present invention relates to a topical solution comprising a retinoid or its pharmaceutically acceptable salts thereof and process of preparing it.
    Type: Grant
    Filed: August 2, 2016
    Date of Patent: July 17, 2018
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Sanjay Kumar Motwani, Vaibhav Dubey, Shashikanth Isloor, Vinod Kumar Arora, Vishnu Datta Maremanda, K. K. Janakiraman, Sumit Madan, Subodh Deshmukh
  • Stable amorphous ticagrelor and a process for its preparation
    Patent number: 10017515
    Abstract: The present invention relates to a stable amorphous ticagrelor and a process for its preparation.
    Type: Grant
    Filed: August 11, 2015
    Date of Patent: July 10, 2018
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Nagaraju Gottumukkala, Anil Saini, Ram Thaimattam, Mahavir Singh Khanna, Mohan Prasad
  • Crystalline form of afatinib dimaleate
    Patent number: 10011591
    Abstract: The present invention provides a crystalline Form I of afatinib dimaleate, its process for preparation and pharmaceutical composition thereof, and its use in the treatment of metastatic non-small cell lung cancer.
    Type: Grant
    Filed: October 1, 2015
    Date of Patent: July 3, 2018
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Shravan Kumar Singh, Shyam Sunder Verma, Kaptan Singh, Mohan Prasad
  • Oral pharmaceutical composition of isotretinoin
    Patent number: 9999606
    Abstract: An oral pharmaceutical composition of isotretinoin and a carrier substrate, having isotretinoin in the form of gel, dispersion, solution or emulsion, which is absorbed onto the carrier substrate to form solid particles, powder, or granules. The oral pharmaceutical composition has enhanced bioavailability. A process is used for preparing the oral composition.
    Type: Grant
    Filed: December 3, 2015
    Date of Patent: June 19, 2018
    Assignee: Sun Pharmaceutical Industries Limited.
    Inventors: Rajesh Rao, Anuj Kumar Fanda, Satish Kumar Jain, Romi Barat Singh
  • PARENTERAL DOSAGE FORM OF NOREPINEPHRINE
    Publication number: 20180140563
    Abstract: The present invention relates to a ready-to-administer parenteral dosage form of norepinephrine which comprises an aqueous solution of norepinephrine, having an anti-oxidant which is not a sulfite anti-oxidant, wherein the dosage form is stable at room temperature for prolonged period of time.
    Type: Application
    Filed: January 19, 2018
    Publication date: May 24, 2018
    Applicant: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Rakesh THUMMAR, Shantaram PAWAR, Prashant KANE, Subhas Balaram BHOWMICK, Samarth KUMAR, Milan Natvarbhai THAKKAR, Kandarp Maheshkumar DAVE
  • Oral liquid compositions of guanfacine
    Patent number: 9962345
    Abstract: The present invention relates to oral liquid compositions of guanfacine. The liquid compositions can be immediate release or extended release compositions. The compositions comprise guanfacine in a concentration from about 0.1 mg/mL to about 12.0 mg/mL of the composition. The liquid compositions can be in the form of ready-to use liquid compositions or reconstituted liquid compositions. It further relates to processes for the preparation of said oral liquid compositions.
    Type: Grant
    Filed: May 2, 2016
    Date of Patent: May 8, 2018
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Romi Barat Singh, Kalaiselvan Ramaraju, Balaram Mondal, Ashish Kumar, Suchitra Kaushik
  • Extended release suspension compositions
    Patent number: 9962336
    Abstract: The present invention relates to a method for preparing a stable extended release suspension composition comprising multiple coated cores of an active ingredient by using a suspension base, wherein the suspension base ensures substantially similar in-vitro dissolution release profile of the active ingredient upon storage of the suspension compositions for at least seven days.
    Type: Grant
    Filed: May 6, 2016
    Date of Patent: May 8, 2018
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Romi Barat Singh, Ashish Kumar, Rajesh Srikrishan Shear, Satish Kumar Jain, Paras P. Jain
  • Crystalline form of baricitinib
    Patent number: 9938283
    Abstract: The present invention provides a crystalline form of baricitinib characterized by an XRPD pattern substantially as depicted in FIG. 1, a process for its preparation, a pharmaceutical composition comprising it, and its use for the treatment of JAK-associated diseases.
    Type: Grant
    Filed: April 29, 2015
    Date of Patent: April 10, 2018
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Gyanendra Pandey, Javeena, Kaptan Singh, Mohan Prasad
  • ONCE DAILY ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN
    Publication number: 20180071240
    Abstract: The present invention relates to a modified-release, once-daily, oral pharmaceutical composition comprising isotretinoin and a process for its preparation. In some embodiments, the disclosure is directed to a modified-release, oral pharmaceutical composition comprising isotretinoin or a pharmaceutically acceptable salt, ester or a derivative thereof; and a release modifying agent, wherein the composition is suitable for once daily administration. In some embodiments, the disclosure is directed to a modified-release, oral pharmaceutical composition comprising isotretinoin, wherein the composition comprises an immediate-release component; and a modified-release component comprising a release modifying agent, and wherein the composition is suitable for once daily administration.
    Type: Application
    Filed: November 24, 2017
    Publication date: March 15, 2018
    Applicant: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Sumit MADAN, Anuj Kumar FANDA, Pankaj Prabhakar AMRUTKAR, Rajesh RAO, Jitendra KAWADKAR, Vasu Kumar KAKUMANU, Ravi KOCHHAR, Romi Barat SINGH, Dileep JAMI, Lokesh GARG, Sandipan ROY
  • Parenteral dosage form of norepinephrine
    Patent number: 9877935
    Abstract: The present invention relates to a ready-to-administer parenteral dosage form of norepinephrine which comprises an aqueous solution of norepinephrine, having an anti-oxidant which is not a sulfite anti-oxidant, wherein the dosage form is stable at room temperature for prolonged period of time.
    Type: Grant
    Filed: August 27, 2015
    Date of Patent: January 30, 2018
    Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Thummar Rakesh, Pawar Shantaram, Kane Prashant, Bhowmick Subhas Balaram, Kumar Samarth, Thakkar Milan Natvarbhai, Dave Kandarp Maheshkumar